Business EconomyPosted at: Apr 15 2026 3:11PM


MSN laboratories launches ‘SEMABEST’ semaglutide in India for type 2 diabetes treatment

Hyderabad, Apr 15 (UNI) MSN Laboratories on Wednesday announced the launch of ‘SEMABEST’, its semaglutide brand, in the Indian market following approval from the Central Drugs Standard Control Organisation (CDSCO).
In a release, the Hyderabad-based pharmaceutical company said the product, indicated for chronic metabolic conditions including Type 2 Diabetes, is priced nearly 50 per cent lower than the innovator drug, aiming to improve affordability and patient access.
The therapy is available as a pre-filled pen for subcutaneous administration.
SEMABEST has demonstrated bioequivalence to the reference drug, supported by Phase III clinical studies showing comparable reduction in HbA1c levels, along with similar outcomes in fasting plasma glucose (FPG), postprandial glucose (PPG) and weight loss. The product also exhibited a comparable safety profile, the release said.
The launch comes amid increasing competition in the segment following the patent expiry of semaglutide, with multiple players entering the market since March 2026.
The company said SEMABEST stands out due to its backward integration, including in-house USDMF-grade API and formulation, along with a pen device manufactured in India in line with global regulatory standards.
India has nearly 90 million people living with diabetes, with a large proportion remaining undiagnosed or inadequately treated, contributing to complications such as cardiovascular disease, kidney failure and vision impairment.
Founder and CMD Dr MSN Reddy said the launch marks a key step in expanding access to next-generation metabolic therapies, while senior officials highlighted the company’s experience in complex peptide development and its global regulatory footprint.
UNI KNR ARN
Please log in to get detailed story.
Tags: #MSN laboratories launches ‘SEMABEST’ semaglutide in India for type 2 diabetes treatment
More News

Countries tapping into oil inventories, strategic reserves at 'record pace': IEA

13 May 2026 | 10:50 PM

Paris, May 13 (UNI) Counties worldwide are now tapping into oil inventories and strategic reserves at a "record pace" due to the "unprecedented" supply disruptions caused by the ongoing Iran war, the International Energy Agency said today.

see more..

Global oil reserves see massive reduction amid Strait of Hormuz disruptions; threaten future price surges – International Energy Agency

13 May 2026 | 7:03 PM

Paris, May 13 (UNI) Global oil reserves are shrinking rapidly due to the disruptions caused by the ongoing US-Israel war against Iran, as well as posing the threat of further oil price surges in the near future, the International Energy Agency (IEA) has warned.

see more..

TVS Motor records 30 pc revenue growth, 40 pc growth in Operating PBT in FY 2025-26

13 May 2026 | 5:52 PM

Chennai, May 13 (UNI) Two and three wheeler makers TVS Motor Company on Wednesday announced that it has posted a highest ever revenue for the 2025-26 fiscal at Rs. 47,270 crores registering a growth of 30% as against Rs. 36,251 crores recorded in 2024-25.

see more..

Sensex, Nifty snap four-day losing streak; metal stocks lead gains

13 May 2026 | 5:42 PM

New Delhi, May 13 (UNI) The Indian Stock Market on Wednesday ended marginally higher after four days of consecutive losses. Strong gains were witnessed in metal, oil-linked, and select heavyweight stocks, offsetting weakness in IT and auto shares.

see more..

CCEA raises MSP for Kharif crops for 2026-27, announces major hike for sunflower, cotton

13 May 2026 | 5:13 PM

New Delhi, May 13 (UNI) The Cabinet Committee on Economic Affairs today approved an increase in the Minimum Support Prices (MSP) for 14 Kharif crops for the 2026-27 marketing season, with the sharpest hikes announced for sunflower seed, cotton, nigerseed and sesamum, as the government sought to ensure higher returns to farmers ahead of the sowing season.

see more..